EV Biologics, Inc. (YECO)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Jun 8, 2026
EV Biologics Market Cap
EV Biologics has a market cap or net worth of $2.05 thousand as of June 18, 2026. Its market cap has decreased by -99.98% in one year.
Market Cap
2.05K
Enterprise Value
n/a
Revenue
9.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 29, 2015, EV Biologics's market cap has decreased from 70.39M to 2.05K, a decrease of -100.00%. That is a compound annual growth rate of -61.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 2.05K | -99.75% |
| Dec 31, 2025 | 829.28K | -15.08% |
| Dec 31, 2024 | 976.52K | -90.45% |
| Dec 20, 2023 | 10.23M | -56.18% |
| Dec 28, 2022 | 23.33M | 109.88% |
| Dec 31, 2021 | 11.12M | -83.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rebus Holdings | 3.21K |
| Comera Life Sciences Holdings | 3.07K |
| eFFECTOR Therapeutics | 2.82K |
| Syros Pharmaceuticals | 2.68K |
| OncoVista Innovative Therapies | 2.36K |
| Suvanza Pharma, LLC | 2.24K |
| Evelo Biosciences | 1.90K |
| Alzex Neuropharma | 1.81K |